Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | AKR1C1 | Q04828 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.42 |
| ▸ | TET3 | O43151 | 2/20 | 0.42 |
| ▸ | FBXL19 | Q6PCT2 | 2/20 | 0.42 |
| ▸ | CXXC5 | Q7LFL8 | 2/20 | 0.42 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.42 |
| ▸ | CXXC4 | Q9H2H0 | 2/20 | 0.42 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.42 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9023593 | 0.91 | AKR1C1 (0.70) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL21101816 | 0.90 | APP (0.55) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL1128270 | 0.90 | AKR1C1 (0.68) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| Phenol SCHEMBL28560131 | 0.87 | AKR1C1 (0.70) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL1335906 | 0.84 | ESR2 (0.48) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL31016196 | 0.81 | AKR1C1 (0.83) | CYP2C19AKR1C1KMT2AMEN1TET3 | |
| SCHEMBL6391 | 0.81 | AKR1C1 (0.83) | CYP2C19AKR1C1KMT2AMEN1TET3 | |
| SCHEMBL518528 | 0.80 | ESR2 (0.45) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL19264980 | 0.80 | ESR2 (0.45) | APPCYP2C19CYP2C9CYP2D6AKR1C1 | |
| SCHEMBL12120029 | 0.80 | ESR2 (0.45) | APPCYP2C19CYP2C9CYP2D6AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109880247-B | Polystyrene electronic carrier tape material containing ultra-dispersed carbon nanotubes and preparation method thereof | 邹晗 | 2022-08-19 | — | — | CN | claimed |
| CN-109880247-A | A kind of polystyrene electronic carrier tape material and preparation method thereof containing ultra-dispersed carbon nanotube | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109880090-A | The polyimides Heat Conduction Material of a kind of containing graphene and carbon nanotube, heat conducting film and preparation method thereof | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109880207-A | A kind of anti-static polyolefin oil pipeline material and preparation method thereof containing ultra-dispersed carbon nanotube | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109825069-A | A kind of Antistatic Nylon material and its application on new-energy automobile component | 华研(佛山)纳米材料有限公司 | 2019-05-31 | — | — | CN | claimed |
| WO-2025050125-A1 | SUBSTITUTED BENZOXAZOLYLAMINO BENZOXAZOLES | IMMVENTION THERAPEUTIX (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-109880247-B | Polystyrene electronic carrier tape material containing ultra-dispersed carbon nanotubes and preparation method thereof | 邹晗 | 2022-08-19 | — | — | CN | disclosed |
| CN-109880247-B | Polystyrene electronic carrier tape material containing ultra-dispersed carbon nanotubes and preparation method thereof | 邹晗 | 2022-08-19 | — | — | CN | disclosed |
| CN-109880247-A | A kind of polystyrene electronic carrier tape material and preparation method thereof containing ultra-dispersed carbon nanotube | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109880247-A | A kind of polystyrene electronic carrier tape material and preparation method thereof containing ultra-dispersed carbon nanotube | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109880207-A | A kind of anti-static polyolefin oil pipeline material and preparation method thereof containing ultra-dispersed carbon nanotube | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109880090-A | The polyimides Heat Conduction Material of a kind of containing graphene and carbon nanotube, heat conducting film and preparation method thereof | 华研(佛山)纳米材料有限公司 | 2019-06-14 | — | — | CN | disclosed |
| US-7223788-B2 | therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-05-29 | — | — | US | disclosed |
| EP-1756063-A1 | AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | Incyte Corporation (US) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006044133-A1 | ACTIVE KETONE INHIBITORS OF TRYPTASE | AXYS PHARMACEUTICALS, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20050282858-A1 | Amido compounds and their use as pharmaceuticals | INCYTE CORPORATION | 2005-12-22 | — | — | US | disclosed |
| WO-2005110992-A1 | AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | INCYTE CORPORATION (US) | 2005-11-24 | — | — | WO | disclosed |
| EP-1597228-A2 | SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2005-11-23 | — | — | EP | disclosed |
| US-20040220191-A1 | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-11-04 | — | — | US | disclosed |
| WO-2004072025-A2 | SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220191-A1 | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments | CYP11B2, CYP11B1, CYP1A1 | APP 4124/4885CYP2C19 6/4885CYP2C9 16/4885 |
| US-20050282858-A1 | Amido compounds and their use as pharmaceuticals | HSD11B1, CYP11B1, HSD11B2 | APP 1198/4885CYP2C19 194/4885CYP2C9 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.